Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Royalty Pharma Plc Cl A
(NQ:
RPRX
)
27.17
-0.24 (-0.88%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Royalty Pharma Plc Cl A
< Previous
1
2
3
4
5
6
Next >
Stocks That Hit 52-Week Lows On Tuesday
September 19, 2023
During Tuesday's session, 275 companies made new 52-week lows.
Via
Benzinga
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
September 05, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
$10M Bet On GameStop? Check Out These 3 Stocks Insiders Are Buying
June 14, 2023
Although US stocks closed higher on Tuesday, there were a few notable insider trades.
Via
Benzinga
Earnings Outlook For Royalty Pharma
May 08, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
Royalty Pharma to Present at Upcoming Investor Conferences
September 05, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma and Ferring Pharmaceuticals Enter Into US $500 Million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (Nadofaragene Firadenovec-Vncg)
August 24, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Stocks That Hit 52-Week Lows On Thursday
September 07, 2023
On Thursday, 283 companies set new 52-week lows.
Via
Benzinga
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
August 24, 2023
From
Ferring Pharmaceuticals
Via
Business Wire
Royalty Pharma Reports Second Quarter 2023 Results
August 08, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
2 Dividend Stocks Wall Street Thinks Can Rise by 50%
July 26, 2023
These stocks could give investors the best of both worlds: dividend income and the potential to earn a great profit.
Via
The Motley Fool
Royalty Pharma to Announce Second Quarter 2023 Financial Results on August 8, 2023
July 18, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Declares Third Quarter 2023 Dividend
July 17, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
$122M Bet On Occidental Petroleum? Check Out These 3 Stocks Insiders Are Buying
June 29, 2023
Although US stocks closed mixed on Wednesday, there were a few notable insider trades.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
June 16, 2023
Friday's session saw 32 companies set new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 15, 2023
On Thursday, 64 companies achieved new lows for the year.
Via
Benzinga
Royalty Pharma to Present at the Goldman Sachs 44th Annual Global Healthcare Conference
June 07, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
Stocks That Hit 52-Week Lows On Wednesday
May 24, 2023
On Wednesday, 129 stocks made new 52-week lows.
Via
Benzinga
$12.5M Bet On Energy Transfer? Check Out These 4 Stocks Insiders Are Buying
May 18, 2023
Although US stocks closed higher on Wednesday, there were a few notable insider trades.
Via
Benzinga
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
May 09, 2023
Via
Benzinga
Royalty Pharma Reports First Quarter 2023 Results
May 09, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma To Present At The BofA Securities 2023 Health Care Conference
May 03, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Declares Second Quarter 2023 Dividend
April 17, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma to Announce First Quarter 2023 Financial Results on May 9, 2023
April 13, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Announces $1.0 Billion Share Repurchase Program
March 27, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma and PureTech Health Enter Into KarXT Royalty Agreement for Up to $500 Million
March 23, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
PureTech Health and Royalty Pharma Enter into KarXT Royalty Agreement for up to $500 Million
March 23, 2023
From
PureTech Health plc
Via
Business Wire
Royalty Pharma Raises Full Year 2023 Guidance
March 15, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
Royalty Pharma Appoints Ashwin Pai as Executive Vice President, Investments
March 01, 2023
From
Royalty Pharma plc
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.